Structure of a bacterial multidrug ABC transporter

Nature

Volumn 443, Issue 7108, 2006, Pages 180-185

  Dawson, Roger J P ^a   Locher, Kaspar P ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; CELL MEMBRANES; CHEMOTHERAPY; CRYSTAL STRUCTURE; CYTOLOGY; DRUG THERAPY; PROTEINS; TOXICITY;

CYTOTOXIC DRUGS; HOMODIMERIC PROTEIN; HUMAN MULTIDRUG RESISTANCE; MULTIDRUG TRANSPORTERS;

CONTROLLED DRUG DELIVERY;

ABC TRANSPORTER; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN SAV1866; UNCLASSIFIED DRUG;

BACTERIUM; CHEMOTHERAPY; CRYSTAL STRUCTURE; CYTOPLASM; DRUG; ELECTRON MICROSCOPY; LIPID; PROTEIN; TRANSLOCATION; TUMOR;

ARTICLE; CRYSTAL STRUCTURE; CYTOPLASM; DIMERIZATION; ELECTRON MICROSCOPY; EXTRACELLULAR SPACE; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 33748644877     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05155     Document Type: Article

References (45)

1. Holland, I. B., Cole, S. P. C., Kuchler, K. & Higgins, C. F. ABC Proteins: From Bacteria to Man (Academic, London, 2003).
2. Gottesman, M. M. & Ambudkar, S. V. Overview: ABC transporters and human disease. J. Bioenerg. Biomembr. 33, 453-458 (2001).
3. Sheppard, D. N. & Welsh, M. J. Structure and function of the CFTR chloride channel. Physiol. Rev. 79, S23-S45 (1999).
4. Lankat-Buttgereit, B. & Tampe, R. The transporter associated with antigen processing: function and implications in human diseases. Physiol. Rev. 82, 187-204 (2002).
5. van Veen, H.W. et al. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature 391, 291-295 (1998).
6. Holland, I. B. & Blight, M. A. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293, 381-399 (1999).
7. Schneider, E. & Hunke, S. ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. FEMS Microbiol. Rev. 22, 1-20 (1998).
8. Shapiro, A. B. & Ling, V. Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270, 16167-16175 (1995).
9. van Veen, H. W., Margolles, A., Muller, M., Higgins, C. F. & Konings, W. N. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J. 19, 2503-2514 (2000).
10. Rosenberg, M. F., Callaghan, R., Modok, S., Higgins, C. F. & Ford, R. C. Three-dimensional structure of P-glycoprotein-the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state. J. Biol. Chem. 280, 2857-2862 (2005).
11. Lee, J. Y., Urbatsch, I. L., Senior, A. E. & Wilkens, S. Projection structure of P-glycoprotein by electron microscopy-evidence for a closed conformation of the nucleotide binding domains. J. Biol. Chem. 277, 40125-40131 (2002).
12. Gaudet, R. & Wiley, D. C. Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing. EMBO J. 20, 4964-4972 (2001).
13. Hopfner, K. P. et al. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101, 789-800 (2000).
14. Smith, P. C. et al. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell 10, 139-149 (2002).
15. Hrycyna, C. A. et al. Mechanism of action of human P-glycoprotein ATPase activity-photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J. Biol. Chem. 273, 16631-16634 (1998).
16. Chen, J., Sharma, S., Quiocho, F. A. & Davidson, A. L. Trapping the transition state of an ATP-binding cassette transporter: evidence for a concerted mechanism of maltose transport. Proc. Natl Acad. Sci. USA 98, 1525-1530 (2001).
17. Vergani, P., Lockless, S. W., Nairn, A. C. & Gadsby, D. C. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433, 876-880 (2005).
18. Senior, A. E. & Bhagat, S. P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites. Biochemistry 37, 831-836 (1998).
19. Locher, K. P., Lee, A. T. & Rees, D. C. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296, 1091-1098 (2002).
20. Stroud, R. M. et al. Glycerol facilitator GlpF and the associated aquaporin family of channels. Curr. Opin. Struct. Biol. 13, 424-431 (2003).
21. Abramson, J., Kaback, H. R. & Iwata, S. Structural comparison of lactose permease and the glycerol-3-phosphate antiporter: members of the major facilitator superfamily. Curr. Opin. Struct. Biol. 14, 413-419 (2004).
22. Stenham, D. R. et al. An atomic detail model for the human ATP binding cassette transporter P-glycoprotein derived from disulphide cross-linking and homology modeling. FASEB J. 17, 2287-2289 (2003).
23. Chang, G. & Roth, C. B. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 293, 1793-1800 (2001).
24. Chang, G. Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. J. Mol. Biol. 330, 419-430 (2003).
25. Reyes, C. L. & Chang, G. Structure of the ABC transporter MsbA in complex with ADP-vanadate and lipopolysaccharide. Science 308, 1028-1031 (2005).
26. Currier, S. J. et al. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. J. Biol. Chem. 267, 25153-25159 (1992).
27. Cotten, J. F., Ostedgaard, L. S., Carson, M. R. & Welsh, M. J. Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271, 21279-21284 (1996).
28. Liu, Y. & Eisenberg, D. 3D domain swapping: as domains continue to swap. Protein Sci. 11, 1285-1299 (2002).
29. Rosenberg, M. F. et al. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle. EMBO J. 20, 5615-5625 (2001).
30. Ramachandra, M. et al. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Biochemistry 37, 5010-5019 (1998).
31. Higgins, C. F. & Linton, K. J. The ATP switch model for ABC transporters. Nature Struct. Mol. Biol. 11, 918-926 (2004).
32. Loo, T. W. & Clarke, D. M. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J. Membr. Biol. 206, 173-185 (2005).
33. Nijenhuis, M. & Hammerling, G. J. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J. Immunol. 157, 5467-5477 (1996).
34. Jardetzky, O. Simple allosteric model for membrane pumps. Nature 211, 969-970 (1966).
35. Patzlaff, J. S., van der Heide, T. & Poolman, B. The ATP/substrate stoichiometry of the ATP-binding cassette (ABC) transporter OpuA. J. Biol. Chem. 278, 29546-29551 (2003).
36. Sauna, Z. E. & Ambudkar, S. V. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc. Natl Acad. Sci. USA 97, 2515-2520 (2000).
37. Shapiro, A. B. & Ling, V. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250, 130-137 (1997).
38. Zelcer, N. et al. Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J. Biol. Chem. 278, 23538-23544 (2003).
39. Moody, J. E., Millen, L., Binns, D., Hunt, J. F. & Thomas, P. J. Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J. Biol. Chem. 277, 21111-21114 (2002).
40. Chen, J., Lu, G., Lin, J., Davidson, A. L. & Quiocho, F. A. A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Mol. Cell 12, 651-661 (2003).
41. Awayn, N. H. et al. Crystallographic and single-particle analyses of native and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Biochem. Soc. Trans. 33, 996-999 (2005).
42. Mannering, D. E., Sharma, S. & Davidson, A. L. Demonstration of conformational changes associated with activation of the maltose transport complex. J. Biol. Chem. 276, 12362-12368 (2001).
43. Kerem, B. S. et al. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic-fibrosis gene. Proc. Natl Acad. Sci. USA 87, 8447-8451 (1990).
44. Tsui, L. C. The spectrum of cystic-fibrosis mutations. Trends Genet. 8, 392-398 (1992).
45. Lewis, H. A. et al. Impact of the ΔF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J. Biol. Chem. 280, 1346-1353 (2005).